Press release
Immunotherapy Drugs Market Opportunity Assessment Study - P&S Intelligence
immunotherapy drugs
North America was the largest immunotherapy drugs market during the historical period, with more than 50.0% contribution in 2017. This can be attributed to the increasing per capita healthcare spending, surging geriatric population, rising prevalence of chronic diseases, and growing presence of market players in the region. Furthermore, factors such as growing research collaborations, increasing number of research laboratories, and growing direct and indirect investments in research and development (R&D) by pharmaceutical and biotechnology companies will also support the growth of the regional market in the coming years.
Access Detailed Report Summary at: https://www.psmarketresearch.com/market-analysis/immunotherapy-drugs-market
Several drugs manufactured by market players for the treatment of chronic diseases are under clinical trials. Thus, increasing use of immunotherapy drugs to combat the rising prevalence of chronic diseases is an important factor driving the market demand. Moreover, thriving demand and development of mAbs, rise in the implementation of target therapy, and increasing availability of biosimilars are also contributing to the growth of the immunotherapy drugs market.
Download Report Sample at: https://www.psmarketresearch.com/market-analysis/immunotherapy-drugs-market/report-sample
The market players in the immunotherapy drugs market are actively seeking collaborations and partnerships for the development of novel immunotherapy drugs. For instance, in April 2018, Bristol-Myers Squibb Company (BMS) and Illumina Inc. collaborated to utilize Illumina’s next-generation sequencing (NGS) technology to develop and globally commercialize in-vitro diagnostic (IVD) assays in support of BMS oncology portfolio. The collaboration helped to develop a diagnostic version of Illumina’s TruSight Oncology 500 assay, including tumor mutation burden (TMB), and microsatellite instability for immunotherapies.
Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=immunotherapy-drugs-market
Some of the other leading players operating in the global immunotherapy drugs market are F. Hoffmann-La Roche Ltd., AbbVie Inc., AstraZeneca PLC, Merck & Co. Inc., GlaxoSmithKline plc, Novartis International AG, Johnson & Johnson, Amgen Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Sanofi, Medigene AG, C. H. Boehringer Sohn AG & Co. KG, Takeda Pharmaceutical Company Limited, and Celgene Corporation.
About P&S Intelligence
P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Immunotherapy Drugs Market Opportunity Assessment Study - P&S Intelligence here
News-ID: 1712062 • Views: …
More Releases from P&S Intelligence
U.S. ESG Investments Market Set to Skyrocket: $16 Trillion by 2032
According to the latest market research study published by P&S Intelligence, the U.S. Environmental, Social, and Governance (ESG) investments market is experiencing a significant surge, with projections indicating an increase from $6.5 trillion in 2024 to an estimated $16.0 trillion by 2032. This represents a robust compound annual growth rate (CAGR) of 12.1% over the forecast period.
According to a comprehensive analysis by P&S Intelligence, the market's expansion is driven…
Facility Management in the U.K. Booms with 14.1% CAGR as Demand Soars Across Sec …
According to the latest market research study published by P&S Intelligence, the U.K. facility management market is poised for significant growth, with projected revenues reaching USD 2,743.3 million in 2024 and expected to soar to USD 6,038.4 million by 2030, reflecting a robust CAGR of 14.1% during the forecast period.
This expansion is fueled by a surge in demand across both public and private sectors. According to the RICS U.K.…
Point-of-Sale Software Market in the U.S. Set to Grow by 9.7% CAGR, Boosted by O …
According to the latest market research study published by P&S Intelligence, the U.S. point-of-sale (POS) software market, valued at USD 4.7 billion in 2024, is poised for significant growth over the coming years, with projections estimating it will reach USD 9.8 billion by 2032, expanding at a compound annual growth rate (CAGR) of 9.7%. This growth is attributed to rapid technological advancements, a surge in mobile and cloud-based POS systems,…
Competitive Landscape of the Industrial Starches Market: Key Players, Trends, an …
According to the latest market research study published by P&S Intelligence, the global industrial starches market is poised for significant growth, with a projected increase from USD 110.3 billion in 2024 to USD 169.9 billion by 2030, at a robust compound annual growth rate (CAGR) of 7.5%. Industrial starches play a crucial role in diverse sectors, including food, pharmaceuticals, and paper, driven by their unique properties such as stabilizing, thickening,…
More Releases for Illumina
Microarray Biochips Market is Booming Worldwide |Illumina,Qiagen,Eppendorf
HTF MI just released the Global Microarray Biochips Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach.
Major companies profiled in Microarray Biochips Market are: Thermo Fisher Scientific,…
Metagenomics Market: Gaining Unprecedented Momentum | Illumina, PerkinElmer
IMR posted new studies guide on Metagenomics Market Insights with self-defined Tables and charts in presentable format. In the Study you may locate new evolving Trends, Drivers, Restraints, Opportunities generated via targeting market related stakeholders. The boom of the Metagenomics marketplace became specifically driven with the aid of the growing R&D spending internationally.
Metagenomics Market Size Was Valued at USD 2.05 Billion in 2023, and is Projected to Reach USD 6.31…
Bioinformatics Market: Know Opportunity Ahead | Illumina, QIAGEN, Wuxi NextCODE
The latest study released on the Global Bioinformatics Market by HTF MI Research evaluates market size, trend, and forecast to 2030. The Bioinformatics market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors.
Key Players in This…
Agrigenomics Market is Booming Worldwide | Illumina, LGC, Eurofins USA
Advance Market Analytics added research publication document on Worldwide Agrigenomics Market breaking major business segments and highlighting wider level geographies to get deep dive analysis on market data. The study is a perfect balance bridging both qualitative and quantitative information of Worldwide Agrigenomics market. The study provides valuable market size data for historical (Volume** & Value) from 2018 to 2023 which is estimated and forecasted till 2028*. Some are the…
Biochips Market Emerging Trends, Size, Share, Growth may Make Driving Growth Vol …
Biochips Market Analysis Report is structured with the meticulous efforts of an innovative, enthusiastic, knowledgeable and experienced team of analysts, researchers, industry experts, and forecasters. This report also offers an in-depth overview of product specification, technology, product type and production analysis considering major factors such as Revenue, Cost, Gross and Gross Margin. Biochips Market analyses the industry based on different factors like growth trends, consumer volume, and market size, demand…
Biochips Market Share 2020-26, Illumina, PerkinElmer, QIAGEN
The latest study on the Global Biochips market report represents a deep appraisal of the international industry. The research report on the worldwide Biochips market 2020-2026 sheds light on qualitative as well as quantitative insights, historical Biochips industry status and authorized projection related to the Biochips market size. Each and every segment exhibited in this report are discovered through verifiable research methods and techniques. It also offers an in-depth overview…
